Topic
Squamous Cell Carcinoma (SCC)
15 Podcasts • 8 Cases • 3 Courses on BackTable
Hear how experienced physicians manage Squamous Cell Carcinoma (SCC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 64 • 09 Jun 2026
Evolving Perioperative Management Strategies for Gastric & GE Junction Cancers
Is personalized, surgery-sparing treatment becoming a reality for patients with gastric adenocarcinoma? In this episode of BackTable Tumor Board, Dr. Eric Lander and Dr. Michael Gibson break down the rapidly changing landscape of treatment for resectable gastric and gastroesophageal junction adenocarcinoma. They trace the evolution from surgery as the standard, through difficult postoperative chemoradiation and perioperative chemotherapy (MAGIC, FLOT4), to the new strategies that are moving beyond traditional chemoradiation in the wake of the ESOPEC trial.
This podcast is supported by
More on Squamous Cell Carcinoma (SCC)
Loading recent podcasts…
Tumor Board # 64
Jun 9, 2026
with Dr. Michael Gibson, Dr. Eric Lander
Is personalized, surgery-sparing treatment becoming a reality for patients with gastric adenocarcinoma? In this episode...
130+ listens
ENT & Allergy # 269
Apr 14, 2026
with Dr. Garret Choby, Dr. Joao Paulo Almeida, Dr. Zara Patel, Dr. Satyan Sreenath
Pathology, anatomy, and staging: how do these three pillars come together to guide sinonasal tumor management? In this...
1,000+ listens
Vascular & IR # 603
Jan 2, 2026
with Dr. Robert Suh, Dr. Alan Lee, Dr. Scott Oh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
1,300+ listens
Vascular & IR # 597
Dec 12, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look...
1,300+ listens
ENT & Allergy # 270
Apr 21, 2026
with Dr. Joao Paulo Almeida, Dr. Zara Patel, Dr. Garret Choby, Dr. Satyan Sreenath
Could that routine epistaxis actually be the first sign of a challenging skull base tumor? This week’s episode of the...
820+ listens
Vascular & IR # 605
Jan 9, 2026
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Scott Oh
Is the open thoracotomy becoming outdated as robotic surgery and advanced ablation techniques take center stage in lung...
1,000+ listens
Tumor Board # 40
Dec 16, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Scott Oh
Is the open thoracotomy becoming outdated as robotic surgery and advanced ablation techniques take center stage in lung...
210+ listens
Tumor Board # 39
Dec 9, 2025
with Dr. Robert Suh, Dr. Scott Oh, Dr. Alan Lee, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
360+ listens
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Nov 21, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 11, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Nov 21, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 11, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.